Latest News & Features
Refine Search
Asia
Israeli company Teva Pharmaceuticals could be forced to pay more than $2 billion in damages for selling a generic version of Nycomed and Pfizer’s heartburn reliever Protonix before the drug’s patent exclusivity expired in the US. 18 February 2013
Asia-Pacific
A judge at Australia’s Federal Court has upheld Myriad Genetics’ patent covering a human gene mutation linked to breast cancer, in the country’s first court ruling on whether isolated genes can be patented. 18 February 2013
Asia
India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step. 14 February 2013
Americas
A US judge has declared pharmaceutical company Bristol-Myers Squibb’s patent covering its hepatitis B treatment Baraclude obvious and invalid. 14 February 2013
Americas
The Mexican Senate has published a bill which, if adopted, will reduce the life term of medicine patents in Mexico by up to one year. 1 February 2013
Asia
India’s patent office has released comments submitted in response to draft examination guidelines for biotechnology patents published in December 2012. 31 January 2013
Americas
Canadian pharmaceutical firms Nuvo Research and Apotex have agreed a patent settlement allowing Apotex to launch a generic version of Nuvo’s arthritis treatment PENNSAID in the US. 31 January 2013
Americas
The University of Wisconsin’s alumni research foundation is suing Florida-based Virtus Pharmaceuticals for selling a calcium supplement it claims knowingly breaches one of its patents. 17 December 2012